FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
By Lori Solomon HealthDay Reporter
MONDAY, July 21, 2025 -- The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).
The existing vaccine consists of two vials -- a lyophilized (powder) antigen and a liquid adjuvant -- that health care professionals combine prior to administration. The new prefilled syringe simplifies the vaccine administration process for health care professionals. The indications for the prefilled syringe are consistent with existing indications for the vaccine. The prefilled syringe presentation is licensed in the United States for immunization of adults 50 years and older, as well as those aged 18 years and older who are or will be at increased risk for shingles due to immunodeficiency or immunosuppression caused by known disease or therapy.
The approval was based on data showing technical comparability between the new and existing vaccine presentation.
"This new presentation of Shingrix was developed to streamline the vaccination process, supporting health care professionals to provide protection against shingles, a disease that one in three U.S. adults will develop in their lifetime," Tony Wood, chief scientific officer at GSK, said in a statement.
Approval of the prefilled syringe presentation of Shingrix was granted to GSK.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Cholera Outbreak in Darfur Kills 40 in One Week, Officials Say
FRIDAY, Aug. 15, 2025 — A fast-moving cholera outbreak in Sudan’s Darfur region has killed 40 people and sickened more than 2,300 in the past week alone, according to...
New Vaccine May Help Stop Deadly Pancreatic Cancers From Coming Back
TUESDAY, Aug. 12, 2025 — A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small clinical trial...
Vinay Prasad Returns to FDA After Being Ousted
MONDAY, Aug. 11, 2025 — The U.S. Food and Drug Administration (FDA)’s top vaccine regulator is returning to his post less than two weeks after the White House had him...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.